“Szemészet” (“Ophthalmology”) is the earliest, uninterruptedly published periodical of the medical disciplines in Hungary. The editorial ambitions have been the same from the very beginning: developing the Hungarian medical terminology, instituting its Hungarian counterparts within practical considerations, providing vocational training, and supporting the scholarship.

The article describes the vision rehabilitation tasks that ophthalmologists do. The most important duty of ophthalmologists is to detect their patients' need for vision rehabilitation and, in this case, provide them the choice of vision rehabilitation while also giving contact information. Visual rehabilitation is necessary for patients with a visual acuity of less than 0.5–0.32, visual field loss, diminished contrast sensitivity, or cerebral visual impairment, or if daily activities such as transportation, self-care, and reading become moderately difficult due to poor vision. Vision rehabilitation can assist patients in improving their independence, ability to work, psychological health, and social well-being.

In this review, the fundamental terms of biometry are presented, as well as the factors influence the precision of intraocular lens calculation, and available methods that improve its potential. Anatomical and pathophysiological features of the high myopic eye are characterised, which influence the precision of intraocular lens calculation fundamentally and limit the selection of intraocular lens. The development of biometry is demonstrated in high-myopic eyes, with suggestions for sophisticated determination to the appropriate intraocular lens power and type. The unconcealed purpose of the study is to encourage our surgeons for using cutting-edge intraocular lens calculation formulas during the biometry of high myopic eyes routinely and to proclaim against the old doctrine, of calculating every high myopic eye to –2.0 D for the prevention of hyperopic postoperative outcomes.

Aim: Presentation of the PreserFlo™ MicroShunt, a minimally invasive aqueous drainage implant, based on our clinical results and international literature data. Patients and methods: Open-angle glaucoma patients were selected from two clinical centres (Department of Ophthalmology, University of Pécs Clinical Centre (10 eyes) and Department of Ophthalmology of Vas County Markusovszky University Teaching Hospital (10 eyes)), for PreserFlo™ MicroShunt implantation, whose elevated intraocular pressure (IOP) could not be controlled with two or more topical antiglaucoma medications and was also associated with visual field progression. Patients with poor adherence or intolerance to topical medications with local and/or systemic side effects were also included (3 cases in the two centres). Results: The PreserFlo™ MicroShunt effectively reduced the intraocular pressure in our patients with known glaucoma, in accordance with the literature. Compared to traditional filtration surgery, the IOP-lowering effect of PreserFloTM did not show a significant difference in the short term. Nevertheless, the MicroShunt seems to have a better risk profile compared to the gold standard trabeculectomy; early postoperative management is simpler, less time-consuming, involves fewer follow-up examinations, and necessitates fewer secondary interventions. Experienced trabeculectomy surgeons show a fast learning curve. Conclusion: Based on our observations, PreserFlo™ shunt implantation can be recommended as a primary choice in well-selected cases of elevated intraocular pressure that cannot be controlled with 2 or more topical antiglaucoma drugs in order to prevent the progression of glaucoma. Further studies are required to confirm the current results.

Purpose: To present a successful outcome case of macular Candida infection with severe SARS-CoV-2 infection. Patient, methods: A 43-year-old, otherwise healthy male patient was intubated and ventilated due to advanced SARS-CoV-2 infection. After 15 days, as his condition improved, he was removed from the ventilator. He noticed a decrease in the vision of the left eye. A general ophthalmic and imaging study (fundus photo, blue autofluorescence and OCT) raised suspicion of a Candida infection located in the parafoveal area. Intensive general and antifungal treatment was applied. The course of the disease was detected with functional and multimodal morphological methods. Results: The general Candida infection spread fungal colonies embedded in the macular choroid and began to sprout. The tendency of this to penetrate into the vitreous through the retina was detected before the breakthrough. The immediate onset of antimycotic treatment confirmed the process diagnostically, and it resolved with minimal loss of macular function. Conclusion: In a SARS-CoV-2 infection with impaired immune status, there is an increased risk of developing a general fungal infection and consequent ophthalmic complications. Recognition of the process in the early phase of the clinical picture and the immediate initiation of antimycotic treatment may prevent the development of severe Candida endophthalmitis.

For the ophthalmologists of the 21st century the implantation of intraocular lenses as part of the surgical treatment of cataracts is an everyday routine. Today it’s hard to even entertain the view dominant in the first half of the past century – then the deliberate placement of an artificial object into the delicate organic structure of the human eye seemed a scandalous, insane idea. The English ophthalmologist Sir Nicholas Harold Lloyd Ridley, inventor of the IOL, took on this seemingly self-evident belief with a determination sustained through decades. His legacy speaks for itself. Today millions of artificial lenses are implanted annually all around the world, the vision of their wearers rectified in a quality hitherto unimaginable. The following essay is the story of the main architect of this reality.